{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:05:16Z","timestamp":1771567516144,"version":"3.50.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Type 2 Diabetes Mellitus (T2DM) is a common comorbidity in late-onset myasthenia gravis (MG), with pre-existing T2DM in some MG patients hinting at a possible pathogenic connection between the two disorders. This study aims to explore the clinical and neurophysiological features of MG, with a particular focus on the electrophysiological disparities between MG patients with and without T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective study, 170 MG inpatients were recruited and divided into T2DM (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f51) and non-T2DM groups. Clinical profiles and electrophysiological characteristics were compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no significant differences between the two groups in terms of MG clinical classification, Quantitative MG (QMG) scores, or antibody profiles. Electrophysiologically, the T2DM group exhibited peripheral neuropathy, characterized by prolonged distal motor latencies, decreased compound muscle action potential (CMAP) amplitudes, slowed motor nerve conduction velocities, extended F-wave latencies, and sensory nerve dysfunction. In low-frequency repetitive nerve stimulation (LFRNS) of the facial nerve, the decrement pattern was predominantly \u201cL-shaped\u201d (minimal recovery) in T2DM patients, in contrast to the \u201cU-shaped\u201d pattern in non-T2DM patients. Accessory nerve LFRNS decrement showed a positive correlation with QMG score, fasting blood glucose levels, and diabetes duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with MG and concomitant T2DM demonstrate electrophysiological evidence of peripheral nerve impairment and a unique \u201cL-shaped\u201d decrement pattern on LFRNS of the facial nerve. This distinct electrophysiological phenotype likely reflects a complex interplay of metabolic derangements at the neuromuscular junction (NMJ). These results highlight the critical role of glycemic control in the management of MG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1776271","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:22:00Z","timestamp":1771564920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and electrophysiological characteristics of myasthenia gravis patients with concomitant type 2 diabetes mellitus"],"prefix":"10.3389","volume":"17","author":[{"given":"Xue-Min","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Dong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Mei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Sheng","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University","place":["Jinan, China"]},{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]},{"name":"Shandong Institute of Neuroimmunology","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/B978-0-12-823912-4.00026-8","article-title":"Myasthenia gravis-pathophysiology, diagnosis, and treatment","volume":"200","author":"Tannemaat","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-323-90820-7.00006-9","article-title":"Myasthenia gravis","volume":"203","author":"Pasnoor","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.irn.2025.04.032","article-title":"Special populations in myasthenia gravis: early, late, and very late-onset Mg","volume":"182","author":"Hoffmann","year":"2025","journal-title":"Int Rev Neurobiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e50017","DOI":"10.7759\/cureus.50017","article-title":"Myasthenia gravis: a systematic review","volume":"15","author":"Mishra","year":"2023","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/jcm13082273","article-title":"Autoimmune and non-autoimmune comorbidities in myasthenic patients of east-European descent: a case-control study","volume":"13","author":"Croitoru","year":"2024","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.3390\/jcm14124221","article-title":"Risk of diabetes mellitus in the myasthenia gravis: a systematic review and meta-analysis","volume":"14","author":"Giannopapas","year":"2025","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12020-024-04143-1","article-title":"Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis","volume":"88","author":"Shao","year":"2025","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1125842","DOI":"10.3389\/fneur.2023.1125842","article-title":"Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study","volume":"14","author":"Liu","year":"2023","journal-title":"Front Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-025-03571-8","article-title":"Diabetes exacerbates myasthenia gravis by enhancing pathological thymic output via the Gpr183-7alpha,25-Ohc axis","volume":"22","author":"Dong","year":"2025","journal-title":"J Neuroinflammation"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e000149","DOI":"10.1136\/bmjph-2023-000149","article-title":"Is a sedentary lifestyle a leading causal factor of obesity and distress in type 2 diabetes? A cross-sectional study in low-socioeconomic areas of Karachi, Pakistan","volume":"1","author":"Sharif","year":"2023","journal-title":"Bmj Public Health"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical guide to glucocorticoid induced hyperglycaemia and diabetes","volume":"14","author":"Barker","year":"2023","journal-title":"Diab Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"109141","DOI":"10.1016\/j.clim.2022.109141","article-title":"Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and activation of circulating Tfh cells","volume":"245","author":"Li","year":"2022","journal-title":"Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-021-02298-6","article-title":"Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity","volume":"18","author":"Zhang","year":"2021","journal-title":"J Neuroinflammation"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.nmd.2021.05.007","article-title":"Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis","volume":"31","author":"Andersen","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"ref15","volume-title":"Repetitive Nerve Stimulation","author":"Datta","year":"2025"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.wneu.2024.08.076","article-title":"Application of electrophysiological techniques in assessing of neuromuscular junction-related disorders","volume":"191","author":"Yang","year":"2024","journal-title":"World Neurosurg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1055\/s-0043-1777749","article-title":"Electrophysiological evaluation of the neuromuscular junction: a brief review","volume":"81","author":"Kouyoumdjian","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/B978-0-444-64142-7.00055-2","article-title":"Clinical neurophysiology of neuromuscular junction disease","volume":"161","author":"Juel","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41582-024-01041-y","article-title":"The global and regional burden of diabetic peripheral neuropathy","volume":"21","author":"Savelieff","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"110764","DOI":"10.1016\/j.diabres.2023.110764","article-title":"Pathogenetic treatments for diabetic peripheral neuropathy","volume":"206","author":"Ziegler","year":"2023","journal-title":"Diab Res Clin Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diab Care"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.clinph.2013.11.007","article-title":"Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?","volume":"125","author":"Sanders","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"ref24","first-page":"242","article-title":"Effects of age, gender, height, and weight on late responses and nerve conduction study parameters","volume":"18","author":"Huang","year":"2009","journal-title":"Acta Neurol Taiwanica"},{"key":"ref25","first-page":"Cr330","article-title":"Nerve conduction study of healthy Asian Malays: the influence of age on median, ulnar, and sural nerves","volume":"13","author":"Awang","year":"2007","journal-title":"Med Sci Monit"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dom.1454727","article-title":"Does poor glycaemic control affect the immunogenicity of the Covid-19 vaccination in patients with type 2 diabetes: the caveat study","volume":"24","author":"Marfella","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diab Care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-2478(02)00032-9","article-title":"Effect of hyperglycemia on the basal cytosolic free calcium level, calcium signal and tyrosine-phosphorylation in human T-cells","volume":"82","author":"Boldizsar","year":"2002","journal-title":"Immunol Lett"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol Belg"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fpsyt.2019.00481","article-title":"Risk of depressive disorders following myasthenia gravis: a nationwide population-based retrospective cohort study","volume":"10","author":"Chu","year":"2019","journal-title":"Front Psych"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"103092","DOI":"10.1016\/j.neucli.2025.103092","article-title":"Is the decrement pattern in myasthenia gravis due to muscle-specific kinase antibodies different to that due to acetylcholine receptor antibodies?","volume":"55","author":"Pegat","year":"2025","journal-title":"Neurophysiol Clin"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.17116\/jnevro20171172193-96","article-title":"Decrement pattern of M-response amplitude in the low-frequency repetitive nerve stimulation in the muscles of patients with myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"117","author":"Tumurov","year":"2017","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11517-016-1462-4","article-title":"Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome","volume":"54","author":"Miralles","year":"2016","journal-title":"Med Biol Eng Comput"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.nmd.2006.05.009","article-title":"Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis","volume":"16","author":"Baslo","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10072-019-04027-7","article-title":"Cmap decrement by low-frequency repetitive nerve stimulation in different hand muscles of Als patients","volume":"40","author":"Zhang","year":"2019","journal-title":"Neurol Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/cm9.0000000000000117","article-title":"Study on variation trend of repetitive nerve stimulation waveform in amyotrophic lateral sclerosis","volume":"132","author":"Fu","year":"2019","journal-title":"Chin Med J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.clinph.2012.08.026","article-title":"Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-Centre experience","volume":"124","author":"Luigetti","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","article-title":"Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy","volume":"17","author":"Sloan","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/s2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/dmrr.2257","article-title":"Motor dysfunction in diabetes","volume":"28","author":"Andersen","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e8763","DOI":"10.1590\/1414-431X20208763","article-title":"Reaching task performance is associated to neuromuscular junction adaptations in rats with induced diabetes mellitus","volume":"53","author":"Estrada-Bonilla","year":"2020","journal-title":"Braz J Med Biol Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2012.10.031","article-title":"The size of motoneurons of the gastrocnemius muscle in rats with diabetes","volume":"531","author":"Muramatsu","year":"2012","journal-title":"Neurosci Lett"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/0471142301.ns0918s29","article-title":"Animal models of painful diabetic neuropathy: the Stz rat model","author":"Morrow","year":"2004","journal-title":"Curr Protoc Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1152\/jappl.2000.89.6.2235","article-title":"Early morphological remodeling of neuromuscular junction in a murine model of diabetes","volume":"89","author":"Fahim","year":"2000","journal-title":"J Appl Physiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/(SICI)1097-0185(199806)251:2<240::AID-AR13>3.0.CO;2-O","article-title":"Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice","volume":"251","author":"Fahim","year":"1998","journal-title":"Anat Rec"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1776271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:22:01Z","timestamp":1771564921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1776271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":45,"alternative-id":["10.3389\/fneur.2026.1776271"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1776271","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"article-number":"1776271"}}